Bausch & Lomb (B&L) has acquired Soothe emolliant eye drops from Alimera Sciences.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Health Canada approves aflibercept biosimilar Aflivu
Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian patients.
Higher Molar Dose and Its Translation into Clinical Practice
Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001
Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia
Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued
A precautionary recall of Zaditen eye drops is issued due to potential microbial contamination, affecting batch 4V64. No adverse events reported.
Nationwide free transport for cataract patients through SpaMedica
SpaMedica to offer free transport for all NHS cataract patients, supporting community care and reducing health inequalities.
Heidelberg Engineering launches ZinserLab innovation hub, expands Orbis collaboration
The imaging innovation project is named after the company's co-founder Gerhard Zinser, PhD